COUNT ON FABRAZYME®.

Fabrazyme is the proven therapy with
over 17 years of real-world experience
and has been chosen for over
5000 patients worldwide, regardless of
genotype or disease severity.1

Blue check mark icon

CHOOSE THE ONLY ERT INDICATED FOR PATIENTS 2 YEARS OF AGE AND OLDER THAT HAS PROVEN LONG TERM EFFICACY AND SAFETY.1


Indication and Usage

Fabrazyme is indicated for the treatment of adult and pediatric patients 2 years of age and older with confirmed Fabry disease.


ERT=Enzyme replacement therapy

Hourglass, time is of the essence for diagnosing and managing Fabry disease.

Time is of the essence for diagnosing and managing Fabry disease.2-4

Fabry disease is a progressive, often life-threatening disease. Undiagnosed and unmanaged, Fabry disease can reduce life expectancy
by approximately 15 years in women and 20 years in men.2-4 Learn more about managing Fabry disease.

References:
  1. Fabrazyme prescribing Information. Cambridge, MA. Genzyme Corporation; 2021.
  2. Ortiz A, Germain DP, Desnick RJ, et al. Mol Genet Metab. 2018;123(4):416-427.
  3. MacDermot KD, Holmes A, Miners AH. J Med Gen. 2001;38(11):750-760.
  4. MacDermot KD, Holmes A, Miners AH. J Med Gen. 2001;38(11):769-775.